Posted in Pharmaceuticals and Healthcare, Total Reads: 959
SWOT Analysis of Hikima Pharmaceuticals with USP, Competition, STP (Segmentation, Targeting, Positioning) - Marketing Analysis
Hikima Pharmaceuticals PLC
Hikma develops, manufactures and markets pharmaceutical products in key therapeutic areas.
Therapeutic areas such as oncology, diabetes and cardiovascular diseases
Healthcare professionals, doctors & hospitals
Hikima aims to provide better access to medicines by delivering high quality, cost effective products to patients
1. Powerful combination of quality products and extensive sales and marketing capabilities sets it apart from competitors in the Middle East and North Africa 2. Successful research and development team 3. Attractive licensing partners 4. Identifying and developing new generic pharmaceutical products
1. Largely dependent on UK’s market for revenue generation 2. Limited presence in emerging markets 3. High reliance on few blockbuster drugs
1. Partner with multinational pharmaceutical companies seeking access to the fast growing MENA markets 2. A strong product pipeline, focused on FDA approved and high-quality products in key therapeutic areas such as oncology, diabetes and cardiovascular diseases 3. Hikma’s facilities in Jordan and Saudi Arabia have been successfully inspected by the FDA, which provides us with the capability to produce products for the US market in the MENA region, at lower costs
1. Stringent drug development guidelines 2. Competition coming up with effective drugs 3. Strict govt policies relating to the pharma industry
The brandnames and other brand information used in the brandguide section are properties of their respective companies. The companies are not associated with MBASkool in any way. The brand names are used purely for educational/academic purpose only. Utmost Care has been taken in the analysis of the brands. However, if you find any ambiguity kindly help us improve.